Investigating how HIF2 affects pancreatic cancer growth
The Role of HIF2 in Pancreatic Ductal Adenocarcinoma
This study is looking at how a specific protein called HIF2 affects the growth of pancreatic cancer and the surrounding support cells, with the hope that understanding this could help create better treatments for patients battling this tough cancer.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Tx Md Anderson Can Ctr NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-11030249 on NIH RePORTER |
What this research studies
This research focuses on pancreatic ductal adenocarcinoma (PDAC), a type of cancer that is difficult to treat due to its unique environment that limits blood flow and nutrient delivery. The study examines the role of hypoxia-inducible factor 2 (HIF2) in cancer-associated fibroblasts (CAFs), which are key components of the tumor's stroma. By using a specialized mouse model, researchers aim to understand how HIF2 influences tumor growth and the immune response within the tumor. The findings could lead to new therapeutic strategies that target the stroma to improve treatment outcomes for patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with pancreatic ductal adenocarcinoma.
Not a fit: Patients with other types of cancer or those not diagnosed with pancreatic ductal adenocarcinoma may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for pancreatic cancer by targeting the tumor environment.
How similar studies have performed: Other research has shown promising results in targeting the tumor microenvironment in various cancers, suggesting potential for success in this approach.
Where this research is happening
Houston, United States
- University of Tx Md Anderson Can Ctr — Houston, United States (Active)
Researchers
- Principal investigator: Koong, Albert — University of Tx Md Anderson Can Ctr
- Study coordinator: Koong, Albert
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.